Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP680401.RAD7ss3iNyVRShsRWbz7YAGMv1W5pTvUp3RB44rsMAWfA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP680401.RAD7ss3iNyVRShsRWbz7YAGMv1W5pTvUp3RB44rsMAWfA130_assertion type Assertion NP680401.RAD7ss3iNyVRShsRWbz7YAGMv1W5pTvUp3RB44rsMAWfA130_head.
- NP680401.RAD7ss3iNyVRShsRWbz7YAGMv1W5pTvUp3RB44rsMAWfA130_assertion description "[Biglycan has been considered a good candidate for neuromuscular disease based on direct interactions with collagen VI and alpha-dystroglycan, both of which are linked with congenital muscular dystrophy (CMD).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP680401.RAD7ss3iNyVRShsRWbz7YAGMv1W5pTvUp3RB44rsMAWfA130_provenance.
- NP680401.RAD7ss3iNyVRShsRWbz7YAGMv1W5pTvUp3RB44rsMAWfA130_assertion evidence source_evidence_literature NP680401.RAD7ss3iNyVRShsRWbz7YAGMv1W5pTvUp3RB44rsMAWfA130_provenance.
- NP680401.RAD7ss3iNyVRShsRWbz7YAGMv1W5pTvUp3RB44rsMAWfA130_assertion SIO_000772 18602826 NP680401.RAD7ss3iNyVRShsRWbz7YAGMv1W5pTvUp3RB44rsMAWfA130_provenance.
- NP680401.RAD7ss3iNyVRShsRWbz7YAGMv1W5pTvUp3RB44rsMAWfA130_assertion wasDerivedFrom befree-2016 NP680401.RAD7ss3iNyVRShsRWbz7YAGMv1W5pTvUp3RB44rsMAWfA130_provenance.
- NP680401.RAD7ss3iNyVRShsRWbz7YAGMv1W5pTvUp3RB44rsMAWfA130_assertion wasGeneratedBy ECO_0000203 NP680401.RAD7ss3iNyVRShsRWbz7YAGMv1W5pTvUp3RB44rsMAWfA130_provenance.